RE:RE:RE:RE:Concordia: long term investors to be rewardedSeeking Alpo pulp makes some nice points and their articles are widely read. So it will help generate some US interest for the day. Thinking longer term, the need to lower healthcare expenditure by 3rd party and government payers for the ageing baby boomers will generate an ideal climate for managed growth for companies who are willing to negotiate formulary access for reduced priced ultragenerics and generics. Currently, having a sales force to promote off patent products will encourage demand by price sensitive physicians, with or without co-pay car cards. CXR pipeline has many new entries in the near and mid term, some are first to market or have limited competition. The entry point at the moment is nice, with minimum down risk, and dividends are paid. Makes for a nice picture.